APO Research
Talk to an analyst

APO RESEARCH · REPORT

Full-Service Clinical Research Organization (CRO)

Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. Full-Service Clinical Research Organization offer a full range of services covering drug development from start to finish. Full-Service Clinical Research Organization offer all the services of regulatory affairs, site selection and activation, site management, monitoring, data management, logistics management, pharmacovigilance, biostatistics, medical writing, and project management.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. Full-Service Clinical Research Organization offer a full range of services covering drug development from start to finish. Full-Service Clinical Research Organization offer all the services of regulatory affairs, site selection and activation, site management, monitoring, data management, logistics management, pharmacovigilance, biostatistics, medical writing, and project management.

Selected research

Market Analysis & Forecast

Global Full-Service Clinical Research Organization (CRO) Market Analysis and Forecast 2026-2032

29 December 2025196 pages

Choose your research edition.

Industry ResearchFull-Service Clinical Research Organization (CRO) Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Full-Service Clinical Research Organization (CRO) Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Full-Service Clinical Research Organization (CRO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Full-Service Clinical Research Organization (CRO) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Full-Service Clinical Research Organization (CRO) Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. Full-Service Clinical Research Organization offer a full range of services covering drug development from start to finish. Full-Service Clinical Research Organization offer all the services of regulatory affairs, site selection and activation, site management, monitoring, data management, logistics management, pharmacovigilance, biostatistics, medical writing, and project management.

Global Full-Service Clinical Research Organization (CRO) key players include IQVIA, Labcorp, Syneos Health, PPD, ICON, etc. Global top three players hold a share about 30%. North America is the largest market, with a share about 45%, followed by APAC and Europe, both have a share about 50 percent.

Report Includes

Read the full market overview

This report presents an overview of global market for Full-Service Clinical Research Organization (CRO), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Full-Service Clinical Research Organization (CRO), also provides the revenue of main regions and countries. Of the upcoming market potential for Full-Service Clinical Research Organization (CRO), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Full-Service Clinical Research Organization (CRO) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Full-Service Clinical Research Organization (CRO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Full-Service Clinical Research Organization (CRO) revenue, projected growth trends, production technology, application and end-user industry.

Full-Service Clinical Research Organization (CRO) Segment by Company

IQVIA

Labcorp

Syneos Health

PPD

ICON

PRA

Parexel

Medpace

Wuxi Apptec

EPS International

Worldwide Clinical Trials

CMIC

Premier Research

Courante Oncology

PROMETRIKA

Full-Service Clinical Research Organization (CRO) Segment by Type

Clinical CRO

Preclinical CRO

Full-Service Clinical Research Organization (CRO) Segment by End Use

Small Medium Enterprise

Large Enterprise

Full-Service Clinical Research Organization (CRO) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Full-Service Clinical Research Organization (CRO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Full-Service Clinical Research Organization (CRO) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Full-Service Clinical Research Organization (CRO).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Full-Service Clinical Research Organization (CRO) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Full-Service Clinical Research Organization (CRO) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Full-Service Clinical Research Organization (CRO) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Clinical CRO Major Player Table 3. Preclinical CRO Major Player Table 4. Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by End Use (US$ Million), 2021 VS 2025 VS 2032 Table 5. Small Medium Enterprise Major Player Table 6. Large Enterprise Major Player Table 7. Full-Service Clinical Research Organization (CRO) Industry Trends Table 8. Full-Service Clinical Research Organization (CRO) Industry Drivers Table 9. Full-Service Clinical Research Organization (CRO) Industry Opportunities and Challenges Table 10. Full-Service Clinical Research Organization (CRO) Industry Restraints Table 11. Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Full-Service Clinical Research Organization (CRO) Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Full-Service Clinical Research Organization (CRO) Market Share by Region (2021-2026) Table 14. Global Full-Service Clinical Research Organization (CRO) Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Full-Service Clinical Research Organization (CRO) Market Share by Region (2027-2032) Table 16. Global Full-Service Clinical Research Organization (CRO) Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Players (2021-2026) Table 18. Global Full-Service Clinical Research Organization (CRO) Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Full-Service Clinical Research Organization (CRO) Key Players Headquarters & Area Served Table 20. Global Full-Service Clinical Research Organization (CRO) Players, Product Type & Application Table 21. Global Full-Service Clinical Research Organization (CRO) Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Full-Service Clinical Research Organization (CRO) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Full-Service Clinical Research Organization (CRO) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Full-Service Clinical Research Organization (CRO) Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Type (2021-2026) Table 28. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Type (2027-2032) Table 29. Global Full-Service Clinical Research Organization (CRO) Revenue by End Use 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2026) & (US$ Million) Table 31. Global Full-Service Clinical Research Organization (CRO) Revenue by End Use (2027-2032) & (US$ Million) Table 32. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by End Use (2021-2026) Table 33. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by End Use (2027-2032) Table 34. IQVIA Company Information Table 35. IQVIA Business Overview Table 36. IQVIA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. IQVIA Full-Service Clinical Research Organization (CRO) Product Portfolio Table 38. IQVIA Recent Development Table 39. Labcorp Company Information Table 40. Labcorp Business Overview Table 41. Labcorp Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Labcorp Full-Service Clinical Research Organization (CRO) Product Portfolio Table 43. Labcorp Recent Development Table 44. Syneos Health Company Information Table 45. Syneos Health Business Overview Table 46. Syneos Health Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Syneos Health Full-Service Clinical Research Organization (CRO) Product Portfolio Table 48. Syneos Health Recent Development Table 49. PPD Company Information Table 50. PPD Business Overview Table 51. PPD Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. PPD Full-Service Clinical Research Organization (CRO) Product Portfolio Table 53. PPD Recent Development Table 54. ICON Company Information Table 55. ICON Business Overview Table 56. ICON Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. ICON Full-Service Clinical Research Organization (CRO) Product Portfolio Table 58. ICON Recent Development Table 59. PRA Company Information Table 60. PRA Business Overview Table 61. PRA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. PRA Full-Service Clinical Research Organization (CRO) Product Portfolio Table 63. PRA Recent Development Table 64. Parexel Company Information Table 65. Parexel Business Overview Table 66. Parexel Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Parexel Full-Service Clinical Research Organization (CRO) Product Portfolio Table 68. Parexel Recent Development Table 69. Medpace Company Information Table 70. Medpace Business Overview Table 71. Medpace Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Medpace Full-Service Clinical Research Organization (CRO) Product Portfolio Table 73. Medpace Recent Development Table 74. Wuxi Apptec Company Information Table 75. Wuxi Apptec Business Overview Table 76. Wuxi Apptec Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Wuxi Apptec Full-Service Clinical Research Organization (CRO) Product Portfolio Table 78. Wuxi Apptec Recent Development Table 79. EPS International Company Information Table 80. EPS International Business Overview Table 81. EPS International Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. EPS International Full-Service Clinical Research Organization (CRO) Product Portfolio Table 83. EPS International Recent Development Table 84. Worldwide Clinical Trials Company Information Table 85. Worldwide Clinical Trials Business Overview Table 86. Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Product Portfolio Table 88. Worldwide Clinical Trials Recent Development Table 89. CMIC Company Information Table 90. CMIC Business Overview Table 91. CMIC Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. CMIC Full-Service Clinical Research Organization (CRO) Product Portfolio Table 93. CMIC Recent Development Table 94. Premier Research Company Information Table 95. Premier Research Business Overview Table 96. Premier Research Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Premier Research Full-Service Clinical Research Organization (CRO) Product Portfolio Table 98. Premier Research Recent Development Table 99. Courante Oncology Company Information Table 100. Courante Oncology Business Overview Table 101. Courante Oncology Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. Courante Oncology Full-Service Clinical Research Organization (CRO) Product Portfolio Table 103. Courante Oncology Recent Development Table 104. PROMETRIKA Company Information Table 105. PROMETRIKA Business Overview Table 106. PROMETRIKA Full-Service Clinical Research Organization (CRO) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. PROMETRIKA Full-Service Clinical Research Organization (CRO) Product Portfolio Table 108. PROMETRIKA Recent Development Table 109. North America Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Full-Service Clinical Research Organization (CRO) Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2026) & (US$ Million) Table 112. North America Full-Service Clinical Research Organization (CRO) Revenue by End Use (2027-2032) & (US$ Million) Table 113. North America Full-Service Clinical Research Organization (CRO) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Full-Service Clinical Research Organization (CRO) Revenue by Country (2021-2026) & (US$ Million) Table 115. North America Full-Service Clinical Research Organization (CRO) Revenue by Country (US$ Million) & (2027-2032) Table 116. Europe Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Full-Service Clinical Research Organization (CRO) Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2026) & (US$ Million) Table 119. Europe Full-Service Clinical Research Organization (CRO) Revenue by End Use (2027-2032) & (US$ Million) Table 120. Europe Full-Service Clinical Research Organization (CRO) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Full-Service Clinical Research Organization (CRO) Revenue by Country (2021-2026) & (US$ Million) Table 122. Europe Full-Service Clinical Research Organization (CRO) Revenue by Country (US$ Million) & (2027-2032) Table 123. China Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2026) & (US$ Million) Table 124. China Full-Service Clinical Research Organization (CRO) Revenue by Type (2027-2032) & (US$ Million) Table 125. China Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2026) & (US$ Million) Table 126. China Full-Service Clinical Research Organization (CRO) Revenue by End Use (2027-2032) & (US$ Million) Table 127. Asia Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Full-Service Clinical Research Organization (CRO) Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2026) & (US$ Million) Table 130. Asia Full-Service Clinical Research Organization (CRO) Revenue by End Use (2027-2032) & (US$ Million) Table 131. Asia Full-Service Clinical Research Organization (CRO) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia Full-Service Clinical Research Organization (CRO) Revenue by Region (US$ Million) & (2021-2026) Table 133. Asia Full-Service Clinical Research Organization (CRO) Revenue by Region (US$ Million) & (2027-2032) Table 134. SAMEA Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2026) & (US$ Million) Table 135. SAMEA Full-Service Clinical Research Organization (CRO) Revenue by Type (2027-2032) & (US$ Million) Table 136. SAMEA Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2026) & (US$ Million) Table 137. SAMEA Full-Service Clinical Research Organization (CRO) Revenue by End Use (2027-2032) & (US$ Million) Table 138. SAMEA Full-Service Clinical Research Organization (CRO) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. SAMEA Full-Service Clinical Research Organization (CRO) Revenue by Country (2021-2026) & (US$ Million) Table 140. SAMEA Full-Service Clinical Research Organization (CRO) Revenue by Country (US$ Million) & (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Full-Service Clinical Research Organization (CRO) Image Figure 2. Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Full-Service Clinical Research Organization (CRO) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Clinical CRO Image Figure 5. Preclinical CRO Image Figure 6. Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by End Use (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Full-Service Clinical Research Organization (CRO) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Small Medium Enterprise Image Figure 9. Large Enterprise Image Figure 10. Global Full-Service Clinical Research Organization (CRO) Market Size (US$ Million) & (2021-2032) Figure 11. Global Full-Service Clinical Research Organization (CRO) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Full-Service Clinical Research Organization (CRO) Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Full-Service Clinical Research Organization (CRO) Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Full-Service Clinical Research Organization (CRO) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Type (2021-2032) Figure 18. Global Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by End Use (2021 VS 2025 VS 2032) Figure 20. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by End Use (2021-2032) Figure 21. North America Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2021-2032) Figure 23. North America Full-Service Clinical Research Organization (CRO) Revenue Share by Application (2021-2032) Figure 24. North America Full-Service Clinical Research Organization (CRO) Revenue Share by Country (2021-2032) Figure 25. United States Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2021-2032) Figure 30. Europe Full-Service Clinical Research Organization (CRO) Revenue Share by Application (2021-2032) Figure 31. Europe Full-Service Clinical Research Organization (CRO) Revenue Share by Country (2021-2032) Figure 32. Germany Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2021-2032) Figure 42. China Full-Service Clinical Research Organization (CRO) Revenue Share by Application (2021-2032) Figure 43. Asia Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2021-2032) Figure 45. Asia Full-Service Clinical Research Organization (CRO) Revenue Share by Application (2021-2032) Figure 46. Asia Full-Service Clinical Research Organization (CRO) Revenue Share by Region (2021-2032) Figure 47. Japan Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2021-2032) Figure 55. SAMEA Full-Service Clinical Research Organization (CRO) Revenue Share by Application (2021-2032) Figure 56. SAMEA Full-Service Clinical Research Organization (CRO) Revenue Share by Country (2021-2032) Figure 57. Brazil Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Full-Service Clinical Research Organization (CRO) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Clinical CRO
  • Preclinical CRO
Applications
  • Small Medium Enterprise
  • Large Enterprise
Companies covered
  • IQVIA
  • Labcorp
  • Syneos Health
  • PPD
  • ICON
  • PRA
  • Parexel
  • Medpace
  • Wuxi Apptec
  • EPS International
  • Worldwide Clinical Trials
  • CMIC
  • Premier Research
  • Courante Oncology
  • PROMETRIKA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Full-Service Clinical Research Organization (CRO) Market by Type
  3. 1.2.1 Global Full-Service Clinical Research Organization (CRO) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Clinical CRO
  5. 1.2.3 Preclinical CRO
  6. 1.3 Full-Service Clinical Research Organization (CRO) Market by End Use
  7. 1.3.1 Global Full-Service Clinical Research Organization (CRO) Market Size by End Use, 2021 VS 2025 VS 2032
  8. 1.3.2 Small Medium Enterprise
  9. 1.3.3 Large Enterprise
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Full-Service Clinical Research Organization (CRO) Market Dynamics
  1. 2.1 Full-Service Clinical Research Organization (CRO) Industry Trends
  2. 2.2 Full-Service Clinical Research Organization (CRO) Industry Drivers
  3. 2.3 Full-Service Clinical Research Organization (CRO) Industry Opportunities and Challenges
  4. 2.4 Full-Service Clinical Research Organization (CRO) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Full-Service Clinical Research Organization (CRO) Market Perspective (2021-2032)
  2. 3.2 Global Full-Service Clinical Research Organization (CRO) Growth Trends by Region
  3. 3.2.1 Global Full-Service Clinical Research Organization (CRO) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Full-Service Clinical Research Organization (CRO) Market Size by Region (2021-2026)
  5. 3.2.3 Global Full-Service Clinical Research Organization (CRO) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Full-Service Clinical Research Organization (CRO) Revenue by Players
  2. 4.1.1 Global Full-Service Clinical Research Organization (CRO) Revenue by Players (2021-2026)
  3. 4.1.2 Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Full-Service Clinical Research Organization (CRO) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Full-Service Clinical Research Organization (CRO) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Full-Service Clinical Research Organization (CRO) Key Players Headquarters & Area Served
  7. 4.4 Global Full-Service Clinical Research Organization (CRO) Players, Product Type & Application
  8. 4.5 Global Full-Service Clinical Research Organization (CRO) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Full-Service Clinical Research Organization (CRO) Market CR5 and HHI
  11. 4.6.3 2025 Full-Service Clinical Research Organization (CRO) Tier 1, Tier 2, and Tier 3
5 Full-Service Clinical Research Organization (CRO) Market Size by Type
  1. 5.1 Global Full-Service Clinical Research Organization (CRO) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2032)
  3. 5.3 Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Type (2021-2032)
6 Full-Service Clinical Research Organization (CRO) Market Size by Application
  1. 6.1 Global Full-Service Clinical Research Organization (CRO) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Full-Service Clinical Research Organization (CRO) Revenue by Application (2021-2032)
  3. 6.3 Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 IQVIA
  2. 7.1.1 IQVIA Company Information
  3. 7.1.2 IQVIA Business Overview
  4. 7.1.3 IQVIA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 IQVIA Full-Service Clinical Research Organization (CRO) Product Portfolio
  6. 7.1.5 IQVIA Recent Developments
  7. 7.2 Labcorp
  8. 7.2.1 Labcorp Company Information
  9. 7.2.2 Labcorp Business Overview
  10. 7.2.3 Labcorp Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Labcorp Full-Service Clinical Research Organization (CRO) Product Portfolio
  12. 7.2.5 Labcorp Recent Developments
  13. 7.3 Syneos Health
  14. 7.3.1 Syneos Health Company Information
  15. 7.3.2 Syneos Health Business Overview
  16. 7.3.3 Syneos Health Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Syneos Health Full-Service Clinical Research Organization (CRO) Product Portfolio
  18. 7.3.5 Syneos Health Recent Developments
  19. 7.4 PPD
  20. 7.4.1 PPD Company Information
  21. 7.4.2 PPD Business Overview
  22. 7.4.3 PPD Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 PPD Full-Service Clinical Research Organization (CRO) Product Portfolio
  24. 7.4.5 PPD Recent Developments
  25. 7.5 ICON
  26. 7.5.1 ICON Company Information
  27. 7.5.2 ICON Business Overview
  28. 7.5.3 ICON Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 ICON Full-Service Clinical Research Organization (CRO) Product Portfolio
  30. 7.5.5 ICON Recent Developments
  31. 7.6 PRA
  32. 7.6.1 PRA Company Information
  33. 7.6.2 PRA Business Overview
  34. 7.6.3 PRA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 PRA Full-Service Clinical Research Organization (CRO) Product Portfolio
  36. 7.6.5 PRA Recent Developments
  37. 7.7 Parexel
  38. 7.7.1 Parexel Company Information
  39. 7.7.2 Parexel Business Overview
  40. 7.7.3 Parexel Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Parexel Full-Service Clinical Research Organization (CRO) Product Portfolio
  42. 7.7.5 Parexel Recent Developments
  43. 7.8 Medpace
  44. 7.8.1 Medpace Company Information
  45. 7.8.2 Medpace Business Overview
  46. 7.8.3 Medpace Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Medpace Full-Service Clinical Research Organization (CRO) Product Portfolio
  48. 7.8.5 Medpace Recent Developments
  49. 7.9 Wuxi Apptec
  50. 7.9.1 Wuxi Apptec Company Information
  51. 7.9.2 Wuxi Apptec Business Overview
  52. 7.9.3 Wuxi Apptec Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Wuxi Apptec Full-Service Clinical Research Organization (CRO) Product Portfolio
  54. 7.9.5 Wuxi Apptec Recent Developments
  55. 7.10 EPS International
  56. 7.10.1 EPS International Company Information
  57. 7.10.2 EPS International Business Overview
  58. 7.10.3 EPS International Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  59. 7.10.4 EPS International Full-Service Clinical Research Organization (CRO) Product Portfolio
  60. 7.10.5 EPS International Recent Developments
  61. 7.11 Worldwide Clinical Trials
  62. 7.11.1 Worldwide Clinical Trials Company Information
  63. 7.11.2 Worldwide Clinical Trials Business Overview
  64. 7.11.3 Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Product Portfolio
  66. 7.11.5 Worldwide Clinical Trials Recent Developments
  67. 7.12 CMIC
  68. 7.12.1 CMIC Company Information
  69. 7.12.2 CMIC Business Overview
  70. 7.12.3 CMIC Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  71. 7.12.4 CMIC Full-Service Clinical Research Organization (CRO) Product Portfolio
  72. 7.12.5 CMIC Recent Developments
  73. 7.13 Premier Research
  74. 7.13.1 Premier Research Company Information
  75. 7.13.2 Premier Research Business Overview
  76. 7.13.3 Premier Research Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Premier Research Full-Service Clinical Research Organization (CRO) Product Portfolio
  78. 7.13.5 Premier Research Recent Developments
  79. 7.14 Courante Oncology
  80. 7.14.1 Courante Oncology Company Information
  81. 7.14.2 Courante Oncology Business Overview
  82. 7.14.3 Courante Oncology Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Courante Oncology Full-Service Clinical Research Organization (CRO) Product Portfolio
  84. 7.14.5 Courante Oncology Recent Developments
  85. 7.15 PROMETRIKA
  86. 7.15.1 PROMETRIKA Company Information
  87. 7.15.2 PROMETRIKA Business Overview
  88. 7.15.3 PROMETRIKA Full-Service Clinical Research Organization (CRO) Revenue and Gross Margin (2021-2026)
  89. 7.15.4 PROMETRIKA Full-Service Clinical Research Organization (CRO) Product Portfolio
  90. 7.15.5 PROMETRIKA Recent Developments
8 North America
  1. 8.1 North America Full-Service Clinical Research Organization (CRO) Revenue (2021-2032)
  2. 8.2 North America Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2032)
  3. 8.2.1 North America Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2026)
  4. 8.2.2 North America Full-Service Clinical Research Organization (CRO) Revenue by Type (2027-2032)
  5. 8.3 North America Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2021-2032)
  6. 8.4 North America Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2032)
  7. 8.4.1 North America Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2026)
  8. 8.4.2 North America Full-Service Clinical Research Organization (CRO) Revenue by End Use (2027-2032)
  9. 8.5 North America Full-Service Clinical Research Organization (CRO) Revenue Share by End Use (2021-2032)
  10. 8.6 North America Full-Service Clinical Research Organization (CRO) Revenue by Country
  11. 8.6.1 North America Full-Service Clinical Research Organization (CRO) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Full-Service Clinical Research Organization (CRO) Revenue by Country (2021-2026)
  13. 8.6.3 North America Full-Service Clinical Research Organization (CRO) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Full-Service Clinical Research Organization (CRO) Revenue (2021-2032)
  2. 9.2 Europe Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Full-Service Clinical Research Organization (CRO) Revenue by Type (2027-2032)
  5. 9.3 Europe Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2032)
  7. 9.4.1 Europe Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2026)
  8. 9.4.2 Europe Full-Service Clinical Research Organization (CRO) Revenue by End Use (2027-2032)
  9. 9.5 Europe Full-Service Clinical Research Organization (CRO) Revenue Share by End Use (2021-2032)
  10. 9.6 Europe Full-Service Clinical Research Organization (CRO) Revenue by Country
  11. 9.6.1 Europe Full-Service Clinical Research Organization (CRO) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Full-Service Clinical Research Organization (CRO) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Full-Service Clinical Research Organization (CRO) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Full-Service Clinical Research Organization (CRO) Revenue (2021-2032)
  2. 10.2 China Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2032)
  3. 10.2.1 China Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2026)
  4. 10.2.2 China Full-Service Clinical Research Organization (CRO) Revenue by Type (2027-2032)
  5. 10.3 China Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2021-2032)
  6. 10.4 China Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2032)
  7. 10.4.1 China Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2026)
  8. 10.4.2 China Full-Service Clinical Research Organization (CRO) Revenue by End Use (2027-2032)
  9. 10.5 China Full-Service Clinical Research Organization (CRO) Revenue Share by End Use (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Full-Service Clinical Research Organization (CRO) Revenue (2021-2032)
  2. 11.2 Asia Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Full-Service Clinical Research Organization (CRO) Revenue by Type (2027-2032)
  5. 11.3 Asia Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2032)
  7. 11.4.1 Asia Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2026)
  8. 11.4.2 Asia Full-Service Clinical Research Organization (CRO) Revenue by End Use (2027-2032)
  9. 11.5 Asia Full-Service Clinical Research Organization (CRO) Revenue Share by End Use (2021-2032)
  10. 11.6 Asia Full-Service Clinical Research Organization (CRO) Revenue by Country
  11. 11.6.1 Asia Full-Service Clinical Research Organization (CRO) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Full-Service Clinical Research Organization (CRO) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Full-Service Clinical Research Organization (CRO) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Full-Service Clinical Research Organization (CRO) Revenue (2021-2032)
  2. 12.2 SAMEA Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Full-Service Clinical Research Organization (CRO) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Full-Service Clinical Research Organization (CRO) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Full-Service Clinical Research Organization (CRO) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2032)
  7. 12.4.1 SAMEA Full-Service Clinical Research Organization (CRO) Revenue by End Use (2021-2026)
  8. 12.4.2 SAMEA Full-Service Clinical Research Organization (CRO) Revenue by End Use (2027-2032)
  9. 12.5 SAMEA Full-Service Clinical Research Organization (CRO) Revenue Share by End Use (2021-2032)
  10. 12.6 SAMEA Full-Service Clinical Research Organization (CRO) Revenue by Country
  11. 12.6.1 SAMEA Full-Service Clinical Research Organization (CRO) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Full-Service Clinical Research Organization (CRO) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Full-Service Clinical Research Organization (CRO) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst